Skip to main content
Aloke Finn, MD, Cardiology, Baltimore, MD

AlokeVirmaniFinnMD

Cardiology Baltimore, MD

Interventional Cardiology

Medical Director CVPath, Clinical Professor University Of Maryland School of Medicine

Dr. Finn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Finn's full profile

Already have an account?

  • Office

    22 S Greene St
    University of Maryland Medical Center
    Baltimore, MD 21201
    Phone+1 301-208-2480

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Interventional Cardiology, 2003
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2000 - 2002
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2000

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2015 - 2026
  • GA State Medical License
    GA State Medical License 2007 - 2017
  • MA State Medical License
    MA State Medical License 2002 - 2009
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Long-Term Vasomotion After Absorb  
    Renu Virmani, Aloke V Finn, ScienceDirect

Lectures

  • Fundamentals of Stent Design: The BP-DES Sweet Spot 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
  • Why SEB Should Be Safer: Insights From Preclinical Study 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019

Authored Content

  • Pathological Mechanisms of Left Main Stent FailureMay 2018
  • Discontinuity Is It a Major Cause of Scaffold Thrombosis?October 2017

Press Mentions

  • Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients
    Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI PatientsMarch 16th, 2022
  • Unraveling the Mystery of Sudden Cardiac Death with Genetic Testing
    Unraveling the Mystery of Sudden Cardiac Death with Genetic TestingSeptember 6th, 2021
  • Genetics of Unexplained Sudden Cardiac Arrest
    Genetics of Unexplained Sudden Cardiac ArrestJune 24th, 2021
  • Join now to see all

Grant Support

  • Mtor Signaling And Vascular Repair In An Experimental Model Of Diabetes MellitusNational Heart, Lung, And Blood Institute2010–2012
  • Defining the Roles of Smooth Muscle Cells and Other Extracellular Matrix Producing Cells in Late Stage Atherosclerotic Plaque PathogenesisLeducq FoundationPresent

Professional Memberships